India's drug regulator has approved what a local vaccine innovator calls the "world's first" intranasal COVID-19 vaccine, restricted for use in emergency situations for those aged 18 years and above. The approval of Bharat Biotech International Ltd.'s iNCOVACC vaccine on Tuesday came two days after China authorized use of an inhalable coronavirus vaccine, another needle-free option. The Hyderabad-based company, in a statement, said the vaccine with the nasal delivery system has been designed to be cost effective in low- and middle-income countries with limited medical facilities and staff. Dru...
